US 10815229
Benzenesulfonamide compounds and their use as therapeutic agents
granted A61PA61P25/08A61P3/12
Quick answer
US patent 10815229 (Benzenesulfonamide compounds and their use as therapeutic agents) held by Xenon Pharmaceuticals Inc. expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Xenon Pharmaceuticals Inc.
- Grant date
- Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61P, A61P25/08, A61P3/12